All treatments
Treatment
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
A Phase IV, open label, single arm trial to assess the safety and immunogenicity of BIMERVAX® LP.8.1 against SARS-CoV-2 variants.
This study is looking at a new COVID-19 vaccine, BIMERVAX LP.8.1, to see how safe it is and how well it helps your body fight off different types of the virus, especially Omicron. It's for people who've already had the vaccine (Phase IV).
For: COVID-19Spain - Ongoing, recruitingTherapeutic use (Phase IV)
COVID-19 vaccine immunological studies in Finland
This study in Finland is looking at how well different COVID-19 vaccines protect people. It's especially interested in how strong our body's defence (antibodies) is six months after two vaccine doses, and how this works against current virus types.
For: COVID-19 infectionFinland